The latest news in renal cancer
With the swift introduction of approved immunotherapy approaches into the treatment landscape for many cancers,…
A combination of the immune checkpoint blocker, , plus the tyrosine kinase inhibitor (TKI), axitinib,…
A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the…
Scientists have discovered that a marker in the blood could help predict the risk that…
I love a good plenary session at ASCO, and this year’s plenary session was one…
A randomized phase III clinical trial showed that many people with advanced kidney cancer can…
“You don’t exactly want your tumour to take home and stick on your mantelpiece -…
The earliest critical genetic changes that can lead to kidney cancer have been mapped by…
Belly fat affects the odds of women surviving kidney cancer but not men, according to…
Combination therapy with two immunotherapy drugs produces an unprecedented doubling of response rates from 20…